Iambic Therapeutics
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
Cadence provides remote patient monitoring and chronic disease management for health systems, clinicians, patients, and payers, using clinical AI to track vitals, symptoms, and medications, flag risks early, and support care teams between visits.
Cadence delivers remote patient monitoring and chronic disease management for health systems, payers, medical groups, and clinicians, combining clinical AI with a multidisciplinary care team to improve outcomes and reduce costs at scale. The platform is designed to extend care beyond the clinic, tracking patient vitals, symptoms, medications, and engagement to flag risks early and enable proactive intervention.
At the core of Cadence is Clinical Intelligence, which continuously monitors patient-generated data such as blood pressure readings, symptom reports, and medication adherence. When a patient's data indicates a potential problem—like a high blood pressure reading or a missed medication—the system flags it for the care team. This early warning allows clinicians to act before a crisis, potentially avoiding emergency department visits or hospitalizations. The platform is built to handle large populations, making it suitable for health systems managing thousands of patients with chronic conditions.
Between visits, AI agents equip the care team to act on patient signals proactively. These agents provide full context and safety guardrails, ensuring that the right call gets made quickly. For example, if a patient reports symptoms or a concerning reading, the AI can suggest a titration or other intervention based on protocols and patient details. The care team, which includes physicians and other clinicians, then reviews and executes the appropriate action. This human-in-the-loop approach aims to combine the efficiency of automation with the judgment of clinical experts.
Cadence's physician-led clinical team extends the practice, supporting patients between visits without adding workload to the existing staff. The team is multidisciplinary, meaning it can address various aspects of chronic care, from medication management to lifestyle coaching. This model is particularly valuable for health systems that want to scale their chronic care programs without hiring additional headcount. The care team is available to patients for consistent support, and the platform facilitates communication and coordination.
Cadence is trusted by more than 20 health systems, and its impact is backed by published research. A study in Mayo Clinic Proceedings: Innovations, Quality & Outcomes found that the program reduced inpatient spend by $1,428 per patient per year. Another study in NEJM Catalyst detailed the mechanics of scaling remote patient care. Additionally, Cadence's HypertensionOS software was announced as the second participant in the FDA's TEMPO program to advance hypertension care. These endorsements and data points suggest that Cadence is making a measurable difference in chronic disease management.
Cadence embeds within real care delivery, meaning every interaction sharpens protocols and strengthens workflows. The platform is designed to fit into existing clinical processes rather than disrupt them. For clinicians, this means less administrative burden and more time for patient care. The system provides suggested titrations and other recommendations based on protocols and patient details, which can be reviewed and approved by the care team. This continuous learning loop helps set a new standard for chronic care.
Cadence serves hospital systems, payers, medical groups, and clinicians. For health systems, it offers scalable care models across populations. For clinicians, it provides extended clinical support without added burden. For patients, it ensures consistent care and support between visits. For payers, it aims for better outcomes with more efficient spend. The platform is particularly suited for organizations managing Medicare patients with chronic diseases, as evidenced by the research focused on this population.
Health systems, payers, and medical groups can explore a partnership with Cadence through their website. Current patients can get help with their Cadence program via the patient support page. The company provides resources such as devices, education, and program information to support patients. While specific pricing is not publicly disclosed, the value proposition centers on cost savings and improved outcomes, which may appeal to payers and providers under value-based care arrangements.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.
Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work. It is built for health systems, health plans, and provider organizations that want to reduce administrative load without adding staff.
IQVIA provides life sciences organizations with data, analytics, and technology to accelerate innovation, improve patient outcomes, and bring treatments to market faster.